These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26966448)

  • 1. Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis.
    Buturak A; Degirmencioglu A; Surgit O; Demir AR; Karakurt H; Erturk M; Yazıcı S; Serteser M; Norgaz T; Gorgulu S
    Postepy Kardiol Interwencyjnej; 2016; 12(1):41-8. PubMed ID: 26966448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study.
    Buturak A; Değirmencioğlu A; Bayrak F; Kırış T; Karakurt H; Demir AR; Sürgit Ö; Ertürk M
    Anatol J Cardiol; 2016 Dec; 16(12):940-946. PubMed ID: 27443475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI).
    Connolly M; Shand J; Kinnin M; Menown I; Kurth MJ; Lamont J; Mc Eneaney D
    QJM; 2018 Jan; 111(1):33-38. PubMed ID: 29040663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
    Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
    Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Peri-procedural Myocardial Infarction in the Era of High Sensitivity Troponin: A Validation of the Joint ACCF/AHA/ESC/WHF Universal Definition of Type 4a Myocardial Infarction with High Sensitivity Troponin T.
    Liou K; Jepson N; Kellar P; Ng B; Isbister J; Giles R; Friedman D; Allan R; Lau A; Pitney M; Ooi SY
    Heart Lung Circ; 2015 Jul; 24(7):673-81. PubMed ID: 25697382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
    Dautov R; Ybarra LF; Nguyen CM; Gibrat C; Joyal D; Rinfret S
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):E308-E316. PubMed ID: 29481724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data.
    Silvain J; Zeitouni M; Paradies V; Zheng HL; Ndrepepa G; Cavallini C; Feldman DN; Sharma SK; Mehilli J; Gili S; Barbato E; Tarantini G; Ooi SY; von Birgelen C; Jaffe AS; Thygesen K; Montalescot G; Bulluck H; Hausenloy DJ
    Eur Heart J; 2021 Jan; 42(4):323-334. PubMed ID: 33257958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and determinants of myocardial infarction following percutaneous coronary interventions according to the revised Joint Task Force definition of troponin T elevation.
    Alcock RF; Roy P; Adorini K; Lau GT; Kritharides L; Lowe HC; Brieger DB; Freedman SB
    Int J Cardiol; 2010 Apr; 140(1):66-72. PubMed ID: 19131135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
    Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
    Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
    Verdoia M; Pergolini P; Barbieri L; Rolla R; Nardin M; Negro F; Suryapranata H; De Luca G;
    Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Chen A; Ma J; Dai C; Lu D; Wu Y; Li S; Chen J; Liu M; Li C; Lu H; Qian J; Ge J
    Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):871-880. PubMed ID: 34962992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Abu Sharar H; Helfert S; Vafaie M; Pleger ST; Chorianopoulos E; Bekeredjian R; Katus HA; Giannitsis E
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):578-585. PubMed ID: 31638330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting.
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Coron Artery Dis; 1996 Jul; 7(7):535-40. PubMed ID: 8913672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Jian W; Guan JH; Zheng WB; Mo CH; Xu YT; Huang QL; Wei CM; Wang C; Yang ZJ; Yang GL; Gui C
    Aging (Albany NY); 2020 Mar; 12(6):5140-5151. PubMed ID: 32182213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.
    Michalak M; Huczek Z; Filipiak KJ; Roik MF; Kochman J; Opolski G
    Kardiol Pol; 2013; 71(4):325-33. PubMed ID: 23788337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.